Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study

Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes

(2013) S. H. Kim et al.   DIABETES CARE

Is there a place for incretin therapies in obesity and prediabetes?

(2013) Jens Juul Holst et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

(2012) Leigh Perreault et al.   LANCET

Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels

(2011) Toshikazu Saito   ARCHIVES OF INTERNAL MEDICINE

Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus

(2010) Eric A. Schwartz et al.   ATHEROSCLEROSIS

Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes

(2010) J. Rosenstock et al.   DIABETES CARE

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Comparison of Three Treatment Approaches to Decreasing Cardiovascular Disease Risk in Nondiabetic Insulin-Resistant Dyslipidemic Subjects

(2008) Fahim Abbasi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome

(2008) Karen Elkind-Hirsch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM